Anti-diabetic models are employed to study glucose metabolism and the effects of new therapies on diabetic conditions. Common models include chemically induced diabetes using streptozotocin or alloxan in rodents. Parameters like blood glucose levels, insulin sensitivity, lipid profiles, and oxidative stress markers are analyzed. These models are crucial for testing the anti-diabetic potential of novel compounds, especially in metabolic disorders often coexisting with cancer.